Within MSH2 variant carriers, the AA genotype of rs2075786 is associated with 85% higher odds of developing cancer compared to MSH2 carriers with the GG genotype (Fig. 2, ORs within MSH2 pathogenic variant carriers only, estimated from the same model as Fig. 1). Here, MSH2 is linked to cancer.